Current Situation and Suggestion of Comprehensive Clinical Evaluation of Medical Products in China in Recent Ten Years
10.13288/j.11-2166/r.2024.04.005
- VernacularTitle:近十年国内药品临床综合评价研究的现状分析与建议
- Author:
Ning DAI
1
;
Qingyun HE
2
;
Fang LU
1
Author Information
1. Xiyuan Hospital， China Academy of Chinese Medical Sciences， Beijing， 100091
2. School of Traditional Chinese Medicine， Beijing University of Chinese medicine
- Publication Type:Journal Article
- Keywords:
clinical comprehensive evaluation of medical products;
Chinese patent medicine;
western medicine;
multi-criteria decision analysis
- From:
Journal of Traditional Chinese Medicine
2024;65(4):357-361
- CountryChina
- Language:Chinese
-
Abstract:
Through analyzing the current situation of clinical comprehensive evaluation researches of domestic medical products from 2013 to 2023， it is found that there is a phenomenon of “four more， four less”. Specifically， there is a greater emphasis on conducting research on drug clinical comprehensive evaluation， but fewer comprehensive evaluation opinions provided； more research data come from publicly available information， but fewer derived from real world； more options for similar reference drugs， but less pre-defined research on reference drugs； the research process involves more steps， yet there are fewer studies strictly implementing quality control. Based on this， suggestions are proposed in three aspects： improving the quality of clinical comprehensive evaluation of medical products， enhancing the transformation and dissemination of results， and improving the standardization of clinical comprehensive evaluation of medical products. Regarding the current state of clinical comprehensive evaluation research on Chinese patent medicine， reflections are presented on elevating original research evidence and highlighting the characteristics and advantages of Chinese patent medicine， so as to promote better transformation and application of the results of clinical comprehensive evaluation of medical products.
